← Open Payments lookup

RAMON SANCHEZ: Open Payments

NPI 1063404408 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,650 in 126 payments from 17 companies in 2025. Trend: 2023 $2,008 · 2024 $2,474 · 2025 $2,650

Food & beverage: $2,628Education: $22
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$479
Neurocrine BioSciences, Inc.17$438
Otsuka America Pharmaceutical, Inc.16$288
Vanda Pharmaceuticals Inc.16$277
Teva Pharmaceuticals USA, Inc.9$213
E.R. Squibb & Sons, L.L.C.12$199
Axsome Therapeutics, Inc.10$175
Janssen Pharmaceuticals, Inc4$126
Lundbeck LLC6$113
Alkermes, Inc.4$76

Products named: CAPLYTA, INGREZZA, FANAPT, COBENFY, REXULTI, ABILIFY ASIMTUFII, Auvelity, UZEDY.

Industry payments across TX — which companies pay providers there.